Alik S Widge Selected Research

benzisothiazole

1/2015

Lurasidone for the treatment of bipolar depression: an evidence-based review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alik S Widge Research Topics

Disease

13	Mental Disorders (Mental Disorder) 03/2022 - 04/2014
6	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2022 - 11/2016
3	Epilepsy (Aura) 01/2022 - 12/2018
2	Parkinson Disease (Parkinson's Disease) 03/2022 - 01/2013
2	Psychotic Disorders (Schizoaffective Disorder) 02/2022 - 09/2020
2	Pain (Aches) 02/2022 - 01/2022
2	Major Depressive Disorder (Major Depressive Disorders) 01/2021 - 11/2013
2	Schizophrenia (Dementia Praecox) 01/2021 - 01/2015
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2020 - 01/2020
2	Treatment-Resistant Depressive Disorder 01/2020 - 01/2018
2	Movement Disorders (Movement Disorder) 12/2018 - 01/2018
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2021
1	Neoplasms (Cancer) 01/2020
1	Anxiety Disorders (Anxiety Disorder) 01/2020
1	Trauma and Stressor Related Disorders 01/2020
1	Hypertension (High Blood Pressure) 11/2019
1	Drug Resistant Epilepsy 07/2019
1	Nervous System Diseases (Neurological Disorders) 07/2019
1	Mania (Manias) 01/2016
1	Weight Gain 01/2015
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2015
1	Nausea 01/2015
1	Delirium 01/2013
1	Paraparesis 03/2009
1	Cauda Equina Syndrome 03/2009
1	Thrombosis (Thrombus) 03/2009
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 03/2007

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 03/2022 - 12/2020
3	Pharmaceutical PreparationsIBA 11/2019 - 01/2015
2	Therapeutic UsesIBA 02/2022 - 01/2020
2	Capsules (Microcapsules)IBA 12/2016 - 01/2016
2	Antipsychotic Agents (Antipsychotics)IBA 01/2015 - 01/2013
1	CannabinoidsIBA 02/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	Hallucinogens (Psychedelics)IBA 01/2020
1	Hormones (Hormone)IBA 01/2020
1	Lysergic Acid Diethylamide (LSD)IBA 01/2020
1	Psilocybin (Psilocibin)IBA 01/2020
1	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2015
1	LipidsIBA 01/2015
1	Lurasidone Hydrochloride FDA Link 01/2015
1	benzisothiazoleIBA 01/2015
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 04/2014

Therapy/Procedure

15	Deep Brain Stimulation 01/2022 - 01/2013
3	Therapeutics 01/2021 - 01/2020
3	Electrodes (Electrode) 12/2020 - 03/2007
1	Defibrillators (Defibrillator) 03/2022
1	Transcranial Direct Current Stimulation 01/2021
1	Terminal Care (Care, Terminal) 01/2020
1	Implanted Electrodes 07/2019
1	Electric Stimulation Therapy (Electrotherapy) 01/2017
1	Neurosurgical Procedures 12/2016
1	Transcranial Magnetic Stimulation 11/2013
1	Perioperative Period 03/2009
1	Anesthesia 03/2009